Caren van Roekel

279 Discussion REFERENCES 1. Bengtsson G, Carlsson G, Hafstrom L, Jonsson PE. Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg. 1981;141:586-9. 2. Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken JH, Aderka D, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27(8):1386-422. Epub 2016/07/07. 3. Nederland Z. Yttrium-90/holmium-166 radioembolisatie bij niet-resectabele colorectale levermetatasen in de salvage setting. 2018. 4. House MG, Ito H, Gonen M, Fong Y, Allen PJ, DeMatteo RP, et al. Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution. J Am Coll Surg. 2010;210(5):744-52, 52-5. Epub 2010/04/28. 5. Leal JN, Bressan AK, Vachharajani N, Gonen M, Kingham TP, D’Angelica MI, et al. Time-to-Surger y and Survival Outcomes in Resectable Colorectal Liver Metastases: A Multi- Institutional Evaluation. J Am Coll Surg. 2016;222(5):766-79. Epub 2016/04/27. 6. Donadon M, Ribero D, Morris-Stiff G, Abdalla EK, Vauthey JN. New paradigm in the management of liver-only metastases from colorectal cancer. Gastrointest Cancer Res. 2007;1(1):20-7. 7. Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term sur vival. Ann Surg. 2004;240(4):644-57; discussion 57-8. Epub 2004/09/24. 8. Vigano L, Capussotti L, Lapointe R, Barroso E, Hubert C, Giuliante F, et al. Early recurrence after liver resection for colorectal metastases: risk factors, prognosis, and treatment. A LiverMetSurvey-based study of 6,025 patients. Ann Surg Oncology. 2014;21(4):1276-86. Epub 2013/12/19. 9. Wurster EF, Tenckhoff S, Probst P, Jensen K, Dolger E, Knebel P, et al. A systematic review and meta-analysis of the utility of repeated versus single hepatic resection for colorectal cancer liver metastases. HPB. 2017;19(6):491-7. Epub 2017/03/30. 10. Sanoff HK, Sargent DJ, Campbell ME, Morton RF, Fuchs CS, Ramanathan RK, et al. Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741. J Clin Oncol. 2008;26(35):5721-7. Epub 2008/11/13. 11. Gillams AR, Lees WR. Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur Radiol. 2009;19(5):1206-13. Epub 2009/01/13. 10